How We're Keeping You Safe | What Patients & Families Need to Know
Member, Division of Bone Marrow Transplantation and Immune Deficiency
Assistant Professor, UC Department of Pediatrics
Dr. Lane joined Cincinnati Children's in July 2013. He has published novel statistical methods in the areas of adaptive and optimal experimental designs with applications to phase I and phase II clinical trials. As a graduate student he received funding from the NIH to spend the fall semester of 2011 at the University of Cambridge in the Isaac Newton Institute for Mathematical Sciences. He has also received NSF travel awards to present his research at national and international conferences.
Clinical trials; survival analysis; structural equation modeling
Experimental Hematology and Cancer Biology, Cancer and Blood Diseases, Biostatistics
Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.
Lazow, MA; Hoffman, L; Schafer, A; Osorio, DS; Boué, DR; Rush, S; Wright, E; Lane, A; DeWire-Schottmiller, MD; Smolarek, T; et al.
Acta Neuropathologica Communications.
MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry.
Leach, JL; Roebker, J; Schafer, A; Baugh, J; Chaney, B; Fuller, C; Fouladi, M; Lane, A; Doughman, R; Drissi, R; et al.
Impact of exogenous antithrombin on low molecular weight heparin anti-Xa activity assays in a pediatric and young adult leukemia and lymphoma cohort with variable antithrombin levels.
Schaefer, B; Hausfeld, A; Martin, M; Steele, P; Martin, J; Reher, SR; Lane, A; Luchtman-Jones, L.
Pediatric Blood and Cancer.
Improving Oral Health and Modulating the Oral Microbiome to Reduce Bloodstream Infections from Oral Organisms in Pediatric and Young Adult Hematopoietic Stem Cell Transplantation Recipients: A Randomized Controlled Trial.
Badia, P; Andersen, H; Haslam, D; Nelson, AS; Pate, AR; Golkari, S; Teusink-Cross, A; Flesch, L; Bedel, A; Hickey, V; et al.
Biology of Blood and Marrow Transplantation.
Adaptive designs for optimal observed Fisher information.
Journal of the Royal Statistical Society: Series B (Statistical Methodology).
A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
DeWire, M; Fuller, C; Hummel, TR; Chow, LM L; Salloum, R; de Blank, P; Pater, L; Lawson, S; Zhu, X; Dexheimer, P; et al.
Journal of Neuro-Oncology.
CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study.
Khandelwal, P; Fukuda, T; Teusink-Cross, A; Kashuba, AD M; Lane, A; Mehta, PA; Marsh, RA; Jordan, MB; Grimley, MS; Myers, KC; et al.
Bone Marrow Transplantation.
Effect of age and neurofibromatosis type 1 status on white matter integrity in the optic radiations.
de Blank, P; Berman, JI; Prelack, M; Sollee, JR; Lane, A; Waldman, AT; Fisher, MJ.
Hydroxyurea dose escalation for sickle cell Anemia in sub-Saharan Africa.
John, CC; Opoka, RO; Latham, TS; Hume, HA; Nabaggala, C; Kasirye, P; Ndugwa, CM; Lane, A; Ware, RE.
The New England journal of medicine.
Genomic variants of cytarabine sensitivity associated with treatment-related mortality in pediatric AML: A report from the children's oncology group.
Phillips, CL; Lane, A; Gerbing, RB; Alonzo, TA; Wilkey, A; Radloff, G; Lange, B; Gamazon, ER; Dolan, ME; Davies, SM.
Clinical Cancer Research.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462
© 1999-2020 Cincinnati Children's Hospital Medical Center. All rights reserved.